Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Jonsson Comprehensive Cancer Center

7 clinical trials · 7 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Jonsson Comprehensive Cancer Center

RECRUITINGPhase 2NCT04553770

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone...

This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 889 locations
Early-stage Breast CancerHormone Receptor Positive Breast CarcinomaInvasive Breast Cancer+4
RECRUITINGEarly Phase 1NCT07235280

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

This early phase I trial tests the safety and side effects of dapagliflozin given prior to surgery in patients with stage IA lung adenocarcinoma. Dapagliflozin is approved by the...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 481 location
Lung AdenocarcinomaStage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8Stage IA2 Lung Cancer AJCC v8+2
RECRUITINGNCT07077239

Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

Single-arm, prospective registry study assessing changes in acute patient-reported urinary (GU) and gastrointestinal (GI) quality of life at the 24-month post-treatment time point...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 2001 location
Prostate Cancer (CRPC)
RECRUITINGEarly Phase 1NCT07164027

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

This early phase I trial evaluates whether a new imaging technique using flotufolastat F 18 (a type of prostate specific membrane antigen \[PSMA\] imaging agent) with positron...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 301 location
Prostate Carcinoma
RECRUITINGPhase 1 / Phase 2NCT06059690

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of...

The purpose of this project is to validate a new combined MRI and PET imaging technique as a biomarker or measure of glycolysis in brain tumors. To accomplish this, the...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 501 location
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
RECRUITINGNCT04742608

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid...

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 2501 location
Thyroid Gland CarcinomaThyroid Gland Nodule
RECRUITINGPhase 2NCT06436612

Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic...

Recent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 201 location
Abdominopelvic Sarcomas